| 1. Ghorai SK, Cook C, Davis M, Venkataraman SK, George C, Beardsley PM, Reith ME, Dutta AK.. (2003) High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo., 46 (7): [PMID:12646032] [10.1021/jm020275k] |
| 2. Hsin LW, Dersch CM, Baumann MH, Stafford D, Glowa JR, Rothman RB, Jacobson AE, Rice KC.. (2002) Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine., 45 (6): [PMID:11882001] [10.1021/jm010430f] |
| 3. Lewis D, Zhang Y, Prisinzano T, Dersch CM, Rothman RB, Jacobson AE, Rice KC.. (2003) Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter., 13 (7): [PMID:12657288] [10.1016/s0960-894x(03)00108-2] |
| 4. Greiner E, Prisinzano T, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC.. (2003) Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine., 46 (8): [PMID:12672246] [10.1021/jm020419v] |
| 5. Goodman MM, Kung MP, Kabalka GW, Kung HF, Switzer R.. (1994) Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2 beta-carbomethoxy-3 beta-(4-chlorophenyl)tropanes: potential dopamine reuptake site imaging agents., 37 (10): [PMID:8182712] [10.1021/jm00036a020] |
| 6. Zhang S, Reith ME, Dutta AK.. (2003) Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter., 13 (9): [PMID:12699762] [10.1016/s0960-894x(03)00169-0] |
| 7. Kolhatkar RB, Ghorai SK, George C, Reith ME, Dutta AK.. (2003) Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine., 46 (11): [PMID:12747792] [10.1021/jm020561w] |
| 8. Newman AH, Allen AC, Izenwasser S, Katz JL.. (1994) Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles., 37 (15): [PMID:8057273] [10.1021/jm00041a002] |
| 9. Bradley AL, Izenwasser S, Wade D, Klein-Stevens C, Zhu N, Trudell ML.. (2002) Synthesis and dopamine transporter binding affinities of 3alpha-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes., 12 (17): [PMID:12161139] [10.1016/s0960-894x(02)00464-x] |
| 10. Hanson RN, Choi S, Elmaleh DR, Fischman AJ. (1997) Synthesis and evaluation of novel-N-[2-(bis-aryl-methoxy)ethyl-N-aralkyl-,-alkanediamines as potent and selective dopamine reuptake inhibitors: Seco analogs of GBR12935 and GBR12909, 7 (20): [10.1016/S0960-894X(97)10053-1] |
| 11. Cao J, Kulkarni SS, Husbands SM, Bowen WD, Williams W, Kopajtic T, Katz JL, George C, Newman AH.. (2003) Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents., 46 (13): [PMID:12801223] [10.1021/jm030008u] |
| 12. Zimmermann K, Hengerer B.. (1998) Design and synthesis of a biotinylated dopamine transporter ligand for the purification and labeling of dopaminergic neurons., 8 (3): [PMID:9871666] [10.1016/s0960-894x(98)00003-1] |
| 13. Bucholtz EC, Brown RL, Tropsha A, Booth RG, Wyrick SD.. (1999) Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors., 42 (16): [PMID:10447948] [10.1021/jm980428x] |
| 14. Cao J, Husbands SM, Kopajtic T, Katz JL, Newman AH.. (2001) [3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4'-fluorophenyl)amine analogues as novel probes for the dopamine transporter., 11 (24): [PMID:11720867] [10.1016/s0960-894x(01)00662-x] |
| 15. Dutta AK, Xu C, Reith ME.. (1998) Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter., 41 (17): [PMID:9703474] [10.1021/jm980066t] |
| 16. Newman AH, Kline RH, Allen AC, Izenwasser S, George C, Katz JL.. (1995) Novel 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors., 38 (20): [PMID:7562926] [10.1021/jm00020a006] |
| 17. Zhang Y, Joseph DB, Bowen WD, Flippen-Anderson JL, Dersch CM, Rothman RB, Jacobson AE, Rice KC.. (2001) Synthesis and biological evaluation of tropane-like 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909) analogues., 44 (23): [PMID:11689080] [10.1021/jm0101592] |
| 18. Myers AM, Charifson PS, Owens CE, Kula NS, McPhail AT, Baldessarini RJ, Booth RG, Wyrick SD.. (1994) Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor., 37 (24): [PMID:7990111] [10.1021/jm00050a008] |
| 19. Hoffman BT, Kopajtic T, Katz JL, Newman AH.. (2000) 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors., 43 (22): [PMID:11063611] [10.1021/jm990472s] |
| 20. Dutta AK, Coffey LL, Reith ME.. (1997) Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity., 40 (1): [PMID:9016326] [10.1021/jm960638e] |
| 21. Prisinzano T, Greiner E, Johnson EM, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC.. (2002) Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter., 45 (19): [PMID:12213078] [10.1021/jm020264r] |
| 22. Husbands SM, Izenwasser S, Kopajtic T, Bowen WD, Vilner BJ, Katz JL, Newman AH.. (1999) Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues., 42 (21): [PMID:10543888] [10.1021/jm9902943] |
| 23. Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FH, Rice KC.. (1996) Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)., 39 (24): [PMID:8941383] [10.1021/jm960305h] |
| 24. Zhang Y, Rothman RB, Dersch CM, de Costa BR, Jacobson AE, Rice KC.. (2000) Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909)., 43 (25): [PMID:11123994] [10.1021/jm000300r] |
| 25. Lewis DB, Matecka D, Zhang Y, Hsin LW, Dersch CM, Stafford D, Glowa JR, Rothman RB, Rice KC.. (1999) Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents., 42 (24): [PMID:10585212] [10.1021/jm990291q] |
| 26. Neumeyer JL, Tamagnan G, Wang S, Gao Y, Milius RA, Kula NS, Baldessarini RJ.. (1996) N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain., 39 (2): [PMID:8558525] [10.1021/jm9505324] |
| 27. Bradley AL, Izenwasser S, Wade D, Cararas S, Trudell ML.. (2003) Synthesis of dopamine transporter selective 3-[2-(diarylmethoxyethylidene)]-8-alkylaryl-8-azabicyclo[3.2.1]octanes., 13 (4): [PMID:12639545] [10.1016/s0960-894x(02)01051-x] |
| 28. Xing D, Chen P, Keil R, Kilts CD, Shi B, Camp VM, Malveaux G, Ely T, Owens MJ, Votaw J, Davis M, Hoffman JM, BaKay RA, Subramanian T, Watts RL, Goodman MM.. (2000) Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography., 43 (4): [PMID:10691690] [10.1021/jm9902234] |
| 29. Dutta AK, Davis MC, Fei XS, Beardsley PM, Cook CD, Reith ME.. (2002) Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules., 45 (3): [PMID:11806716] [10.1021/jm010316x] |
| 30. Dutta AK, Coffey LL, Reith ME.. (1998) Potent and selective ligands for the dopamine transporter (DAT): structure-activity relationship studies of novel 4-[2-(diphenylmethoxy)ethyl]-1-(3-phenylpropyl)piperidine analogues., 41 (5): [PMID:9513598] [10.1021/jm970595h] |
| 31. Matecka D, Lewis D, Rothman RB, Dersch CM, Wojnicki FH, Glowa JR, DeVries AC, Pert A, Rice KC.. (1997) Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors., 40 (5): [PMID:9057857] [10.1021/jm9606599] |
| 32. Dutta AK, Xu C, Reith ME.. (1996) Structure-activity relationship studies of novel 4-[2-[bis(4-fluorophenyl)methoxy]ethyl]-1-(3-phenylpropyl)piperidine analogs: synthesis and biological evaluation at the dopamine and serotonin transporter sites., 39 (3): [PMID:8576918] [10.1021/jm9506581] |
| 33. Dutta AK, Fei XS, Beardsley PM, Newman JL, Reith ME.. (2001) Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters., 44 (6): [PMID:11300876] [10.1021/jm000311k] |
| 34. Carroll FI, Lewin AH, Boja JW, Kuhar MJ.. (1992) Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter., 35 (6): [PMID:1552510] [10.1021/jm00084a001] |
| 35. Zhang S, Zhen J, Reith ME, Dutta AK.. (2005) Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner., 48 (15): [PMID:16033275] [10.1021/jm049021k] |
| 36. Lapa GB, Byrd GD, Lapa AA, Budygin EA, Childers SR, Jones SR, Harp JJ.. (2005) The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines., 15 (22): [PMID:16165350] [10.1016/j.bmcl.2005.08.028] |
| 37. Zhang S, Fernandez F, Hazeldine S, Deschamps J, Zhen J, Reith ME, Dutta AK.. (2006) Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters., 49 (14): [PMID:16821783] [10.1021/jm0601699] |
| 38. Cao J, Lever JR, Kopajtic T, Katz JL, Pham AT, Holmes ML, Justice JB, Newman AH.. (2004) Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter., 47 (25): [PMID:15566284] [10.1021/jm049670w] |
| 39. Gilbert KM, Boos TL, Dersch CM, Greiner E, Jacobson AE, Lewis D, Matecka D, Prisinzano TE, Zhang Y, Rothman RB, Rice KC, Venanzi CA.. (2007) DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods., 15 (2): [PMID:17127069] [10.1016/j.bmc.2006.09.070] |
| 40. Mishra M, Kolhatkar R, Zhen J, Parrington I, Reith ME, Dutta AK.. (2008) Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an exocyclic hydroxyl group: interaction with dopamine, serotonin, and norepinephrine transporters., 16 (6): [PMID:18249549] [10.1016/j.bmc.2008.01.009] |
| 41. Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP.. (2008) Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity., 51 (14): [PMID:18588282] [10.1021/jm701575k] |
| 42. Hsin LW, Chang LT, Rothman RB, Dersch CM, Jacobson AE, Rice KC.. (2008) Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters., 51 (9): [PMID:18393401] [10.1021/jm701270n] |
| 43. Cao J, Kopajtic T, Katz JL, Newman AH.. (2008) Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol., 18 (19): [PMID:18774292] [10.1016/j.bmcl.2008.08.065] |
| 44. White JD, Juniku R, Huang K, Yang J, Wong DT.. (2009) Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters., 52 (19): [PMID:19791802] [10.1021/jm900847b] |
| 45. Hojahmat M, Horton DB, Norrholm SD, Miller DK, Grinevich VP, Deaciuc AG, Dwoskin LP, Crooks PA.. (2010) Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters., 18 (2): [PMID:20036131] [10.1016/j.bmc.2009.12.002] |
| 46. PubChem BioAssay data set, |
| 47. PubChem BioAssay data set, |
| 48. PubChem BioAssay data set, |
| 49. PubChem BioAssay data set, |
| 50. PubChem BioAssay data set, |
| 51. Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, Ohashi K.. (2010) Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships., 18 (21): [PMID:20875743] [10.1016/j.bmc.2010.07.034] |
| 52. Nencetti S, Mazzoni MR, Ortore G, Lapucci A, Giuntini J, Orlandini E, Banti I, Nuti E, Lucacchini A, Giannaccini G, Rossello A.. (2011) Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors., 46 (3): [PMID:21272963] [10.1016/j.ejmech.2010.12.018] |
| 53. Lebar MD, Hahn KN, Mutka T, Maignan P, McClintock JB, Amsler CD, van Olphen A, Kyle DE, Baker BJ.. (2011) CNS and antimalarial activity of synthetic meridianin and psammopemmin analogs., 19 (19): [PMID:21907583] [10.1016/j.bmc.2011.08.033] |
| 54. PubChem BioAssay data set, |
| 55. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 56. PubChem BioAssay data set, |
| 57. Han M, Song C, Jeong N, Hahn HG.. (2014) Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine., 5 (9): [PMID:25221656] [10.1021/ml500187a] |
| 58. Xu R, Lord SA, Peterson RM, Fergason-Cantrell EA, Lever JR, Lever SZ.. (2015) Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters., 23 (1): [PMID:25468036] [10.1016/j.bmc.2014.11.007] |
| 59. Wiśniowska B, Mendyk A, Fijorek K, Glinka A, Polak S.. (2012) Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment., 32 [PMID:22761000] [10.1002/jat.2784] |
| 60. Cao J, Slack RD, Bakare OM, Burzynski C, Rais R, Slusher BS, Kopajtic T, Bonifazi A, Ellenberger MP, Yano H, He Y, Bi GH, Xi ZX, Loland CJ, Newman AH.. (2016) Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors., 59 (23): [PMID:27933960] [10.1021/acs.jmedchem.6b01373] |
| 61. Paudel S, Acharya S, Yoon G, Kim KM, Cheon SH.. (2017) Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors., 25 (7): [PMID:28274674] [10.1016/j.bmc.2017.02.051] |
| 62. Paudel S, Min X, Acharya S, Khadka DB, Yoon G, Kim KM, Cheon SH.. (2017) Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles., 25 (20): [PMID:28807575] [10.1016/j.bmc.2017.07.046] |
| 63. Felts AS, Rodriguez AL, Morrison RD, Bollinger KA, Venable DF, Blobaum AL, Byers FW, Thompson Gray A, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA.. (2017) Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5., 27 (21): [PMID:28958625] [10.1016/j.bmcl.2017.09.042] |
| 64. Unpublished dataset, |
| 65. Sun H, Shi M, Zhang W, Zheng YM, Xu YZ, Shi JJ, Liu T, Gunosewoyo H, Pang T, Gao ZB, Yang F, Tang J, Yu LF.. (2016) Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy., 59 (13): [PMID:27309376] [10.1021/acs.jmedchem.6b00571] |
| 66. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 67. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 68. Mehr-Un-Nisa, Munawar MA, Rankin D, Hruby VJ, Porreca F, Lee YS.. (2021) C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters., 51 [PMID:34798381] [10.1016/j.bmc.2021.116509] |
| 69. Hubert J. Sijben; Wieke M. van Oostveen; Peter B. R. Hartog; Laura Stucchi; Andrea Rossignoli; Giovanna Maresca; Lia Scarabottolo; Adriaan P. IJzerman; Laura H. Heitman. (2021) Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors, 11 (1): [PMID:34112854] [10.1038/s41598-021-91700-7] |
